Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FAST +4.9%, VSCO +2.8% (guidance), DAL +2.3%, QDEL +1.7%, RELL +1.2%
Other news:
- ATXS +9% (exclusive license agreement with Ichnos; prices $64 mln underwritten offering)
- BLRX +8.7% (closing of exclusive license agreement to motixafortide in Asia and concurrent strategic equity investment)
- OMGA +4.2% (to present data)
- SRRK +3.6% (advancing antimyostatin program; prices offering of 12408760 shares of its common stock at $6.85)
- NEOG +3.3% (CFO bought 10000 shares worth more than $150K (transaction date 10/11))
- EBR +1.9% (provides Voluntary Dismissal Plan update)
- ALB +1.9% (Liontown Resources Limited provides update on ALB proposal)
- VTLE +1.7% (reports total production figures for Q3)
- CERE +1.3% (prices offering of 19728189 shares of common stock $22.81 per share)
- XPEL +1.2% (confirms it is currently in discussions with multiple OEM's about adding new or expanding existing programs for XPEL products)
Analyst comments:
- WRBY +2.7% (upgraded to Buy from Neutral at BTIG Research)
- CLX +1.1% (upgraded to Mkt Perform from Underperform at Bernstein)